002919.SZ
名臣健康
SZSE · Consumer Defensive · I 信息技术 · CN
CNY 16.92
−2.20%Year over year
Reported trailing growth
- Revenue
- +13.8%
- EBITDA
- —
- EBIT
- +2169.4%
- EPS
- +69.2%
- Free cash flow
- -22.9%
- Operating cash flow
- +7.8%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +17.0%
- EBITDA
- +25.3%
- EBIT
- -2.8%
- Net income
- +3.7%
- EPS
- -1.2%
- Free cash flow
- -85.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026